Related Experiment Video
Updated: Nov 15, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019
Jing-Yi Qian1, Bin Wang1, Lin-Li Lv1
1Institute of Nephrology, Zhong Da Hospital, Southeast University School of Medicine, Nanjing, China.
Insights
Acute kidney injury (AKI) is a serious complication of Coronavirus Disease 2019 (COVID-19), impacting patient survival. This review explores the complex factors contributing to AKI pathogenesis in COVID-19 patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus Disease 2019 (COVID-19) is a global pandemic primarily causing respiratory illness.
- Acute kidney injury (AKI) is a significant extrapulmonary complication of COVID-19, affecting patient prognosis and mortality.
- The precise mechanisms underlying AKI in COVID-19 remain incompletely understood.
Purpose of the Study:
- To review and synthesize current knowledge on the pathogenesis of acute kidney injury (AKI) in the context of COVID-19.
- To elucidate the multifactorial contributors to AKI development in COVID-19 patients.
- To provide a comprehensive overview of the proposed mechanisms linking SARS-CoV-2 infection to kidney damage.
Main Methods:
- Literature review of existing studies on COVID-19 and acute kidney injury.
- Analysis of proposed etiological factors for AKI in COVID-19.
- Synthesis of information regarding intrarenal, pre-renal, and post-renal mechanisms.
Main Results:
- Multiple factors contribute to AKI in COVID-19, including direct viral effects, immune dysregulation, and medication toxicity.
- Intrarenal, pre-renal, and post-renal pathways are implicated in COVID-19-associated AKI.
- Coagulation abnormalities, sepsis, and pre-existing conditions exacerbate AKI risk.
Conclusions:
- The pathogenesis of AKI in COVID-19 is complex and multifactorial.
- Understanding these mechanisms is crucial for improving patient outcomes and developing targeted therapies.
- Further research is needed to fully elucidate the intricate pathways leading to AKI in COVID-19.
Abstract:
Since the outbreak of Coronavirus Disease 2019 (COVID-19) in Wuhan, China, in December of 2019, it has rapidly become a global pandemic. Although acute respiratory disorder is the main manifestation of COVID-19, acute kidney injury (AKI) is another important extrapulmonary complication, which has a critical impact on the prognosis and mortality of patients. Current understanding about the exact pathogenesis of AKI in COVID-19 is unclear. Several studies have suggested that intrarenal, pre-renal and post-renal factors mediated collaboratively by direct virus attack, overloaded immune responses, drugs, sepsis, coagulation dysfunction, and underlying diseases may all be involved in the pathogenesis of AKI. This article reviews the current understanding of the pathogenesis of AKI in COVID-19.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction
Acute Kidney Injury VI: Nursing Management

